Dear Friends & Colleagues,
I am glad to wish you 'Merry Christmas' and 'Happy New Year' in advance, on behalf of Oviya MedSafe - your strategic partner for Global Pharmacovigilance, through the December 2012 edition of our monthly newsletter!
In this edition, I am happy to share with you the recently evolved Vision, Mission and Value statements of Oviya MedSafe! Crafted with a lot of zeal and genuineness, we have ensured that these statements reflect our undaunted commitment towards pharmacovigilance, as follows:
- To become a leader in pharmacovigilance consulting services by strategically partnering with global pharmaceutical companies.
- To inculcate a pharmacovigilant culture and proactively support the growth of drug safety practices across the globe. We will achieve this by integrating our expertise in pharmacovigilance with our medical experience, ensuring compliance to the dynamic regulatory frameworks and deploying the most appropriate technology.
- Passion for Pharmacovigilance
- Continuous learning to empower clients
- Perpetual capability building
- Deep-rooted business integrity
We firmly believe that these core statements will be the key stimulants for our growth and development. We trust we will be able to make a significant difference not only in India but globally as well, in our highly focused single-minded objective of pharmacovigilance.
I would also take this opportunity to share with you my second publication in 2012 (on Pioglitazone) titled "Eight Cases of Bladder Cancer in Pioglitazone users from India" published in the Correspondence section of the Journal of the Association of Physicians of India in its December 2012 issue, which can be freely read here: http://www.japi.org/december_2012/18_correspondences.html. It is my privileged duty to thank all my co-authors who made this publication possible, especially the corresponding author Dr V Mohan.
I am particularly pleased to mention here about the 'Pharmacovigilance India' LinkedIn Group (http://www.linkedin.com/groups?home=&gid=839337) founded by me on 12-Sep-2008, which had its 3000th member on 13-Dec-2012. We at 'Pharmacovigilance India' wish to grow more and more in numbers as well as in our understanding on what we want to achieve together so that we emerge as a solid support group for all Pharmacovigilance activities in India, in the years to come.
Another important activity we had this month was my talk titled "Pharmacovigilance - An Emerging Medical Specialty" at MEDITEX 2012 - the 67th Annual Conference of the Indian Medical Association (Tamil Nadu State Branch) at Coimbatore on 16-Dec-2012. The idea of the talk was to showcase pharmacovigilance as a career option for young doctors in India. I am hopeful that bigger numbers of doctors in India will look at the option of taking pharmacovigilance as their careers, very soon.
Follow us on:
With thanks & regards,
Dr Vijay Venkatraman Janarthanan.
Founder & CEO,
Oviya MedSafe Pvt. Ltd.
2nd Floor, KTVR Gardens
220a-3, Marudha Konar Road,
Coimbatore - 641 025.
Tamil Nadu, India.